Conflicting data released this week from two ongoing prostate cancer studies may cause further public confusion over the benefits of screening. We discuss the latest treatments and research on prostate cancer.

James Brooks, associate professor of urology at the Stanford University School of Medicine
Kirsten Greene, urologic cancer surgeon at the UCSF Helen Diller Family Comprehensive Cancer Center
Otis Brawley, chief medical officer of the American Cancer Society

Sponsored by

Become a KQED sponsor